Related Experiment Video
Updated: Aug 2, 2026
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
The first structure of a microsomal P450--implications for drug discovery
Current Opinion in Drug Discovery & Development
|June 27, 2003
Summary
The first crystal structure of a membrane-associated P450 provides new insights into its function. This breakthrough aids in accurately modeling other P450 enzymes and understanding drug targets.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Microbial, soluble P450 structures have been extensively studied.
- Microsomal, membrane-associated P450 structures remained elusive until recently.
Purpose of the Study:
- To present the first crystal structure of a microsomal, membrane-associated P450.
- To elucidate the binding surfaces for membranes, substrates, and reductases.
- To improve the accuracy of modeling other P450 enzymes.
Main Methods:
- X-ray crystallography was employed to determine the structure of the membrane-associated P450.
- Comparative modeling techniques were utilized, informed by the new structural data.
Main Results:
- The determined structure reveals key features of the membrane, substrate, and reductase binding sites.
- This structural information enables more accurate modeling of other P450 proteins.
- Milestones include the structure of a P450 drug target (CYP51), a thermophilic P450, and trapped reaction intermediates.
Conclusions:
- The structure of membrane-associated P450 significantly advances the understanding of these critical enzymes.
- This work provides a foundation for future structural and functional studies of P450s.
- The findings have implications for drug development and enzyme engineering.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...